Findings from a new study conducted by a team of researchers at Dartmouth's Geisel School of Medicine and Thayer School of Engineering and published in Cell Reports Medicine offer new insights into how antibodies function ...
Feb 12, 2024
0
66
Is herpes always contagious or only during outbreaks? Does the pill cause long-term infertility issues? And was female "hysteria" really treated with orgasms by doctors in the past? Every year, there is an entire week dedicated ...
Feb 8, 2024
0
0
Two doses of recombinant zoster vaccine (RZV) are effective against herpes zoster (HZ), with the vaccine effectiveness (VE) of two doses waning a little over four years of follow-up, according to a study published online ...
Jan 9, 2024
0
1
Herpes simplex virus (HSV) is extremely common, affecting nearly two-thirds of the world's population, according to the World Health Organization.
Dec 14, 2023
0
45
The effectiveness of the live zoster (shingles) vaccine is highest in the first year after vaccination and then wanes substantially. But it continues to provide some protection against shingles and its complications ten years ...
Nov 8, 2023
0
16
Researchers from LSTM, in collaboration with researchers in Kenya and the U.S., have been investigating options for girls and young women in low-and-middle-income countries to manage menstruation with comfort and dignity ...
Oct 17, 2023
0
0
HPV, or human papillomavirus, is the most common sexually transmitted infection. It is also the leading cause of cervical cancer. Over 1,400 Canadian women are affected yearly, with almost 400 deaths, according to the Canadian ...
Oct 2, 2023
0
1
Aging has been identified as a significant risk factor for herpes zoster, a skin disease caused by the same virus that causes chickenpox. With the aging of the population, the prevalence of herpes zoster infection is increasing ...
Sep 21, 2023
0
21
Herpes is not only unpleasant but it can, in some cases, also have dangerous complications and life-threatening consequences. In the journal Angewandte Chemie, a research team has now introduced a completely new approach ...
Sep 7, 2023
0
67
The U.S. Food and Drug Administration approved Tyruko (natalizumab-sztn), the first biosimilar to Tysabri (natalizumab) injection, for the treatment of relapsing forms of multiple sclerosis, the agency announced Thursday.
Aug 27, 2023
0
2
